Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest

Initial search results include only NCI-sponsored clinical trials. To search all trials, click the "REFINE SEARCH" button, scroll down to the Trial ID/Sponsor section and select the "All" check box in the Sponsor of Trial section.

View Content for:
Display:
?
Drug:  imexon
Find trials that include:  Any drugs shown
Trial Status:  Closed
Results 1-7 of 7 for your search:
Start Over
Phase I/II Study of Imexon and Dacarbazine in Patients With Chemotherapy-Naive Unresectable Stage III or IV Melanoma
Phase: Phase II, Phase I
Type: Treatment
Status: Closed
Age: unspecified
Sponsor: NCI, Pharmaceutical / Industry
Protocol IDs: AMP-005, UCLA-0504069, NCT00327600
Safety and Efficacy Study of Imexon for Treatment of Multiple Myeloma Patients
Phase: Phase II, Phase I
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: AMP-007, NCT00327249
A Randomized Study of Amplimexon (Imexon) With Gemcitabine in Pancreatic Cancer
Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: AMP-019, NCT00637247
Imexon for Relapsed Follicular and Aggressive Lymphomas
Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Closed
Age: 18 and over
Sponsor: Other
Protocol IDs: 36191, NCT01314014
Safety Study of Imexon Treatment of Patients With Metastatic or Disseminated Malignancy
Phase: Phase I
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: AMP-011, NCT00327223
Safety Study of Imexon Plus Docetaxel in Lung, Breast or Prostate Cancer Patients
Phase: Phase I
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: AMP-010, NCT00327288
Safety Study of Imexon Plus Gemcitabine in Untreated Pancreatic Adenocarcinoma
Phase: Phase I
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: AMP-004, NCT00327327
Start Over